inside the swiftly evolving subject of cancer therapeutics, knowing the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is vital for establishing successful treatment plans. The most promising strategies is the use of in vitro bystander effect assays, which Perform a pivotal part in improving therapeutic efficacy. These assays, furnished by